Table 1.

Demographic characteristic of anticancer drugs related Stevens-Johnson syndrome and toxic epidermal necrolysis for patients reported in the FAERS Database.

Characteristics		SJS/TEN reports (N=3471)
Age, years
	< 18	172 (5.0%)
	18-65	1301 (37.5%)
	> 65	1151 (33.2%)
	Unknown	847 (24.4%)
	Median [Q1, Q3]	64 [52,71]
Gender
	Female	1600 (46.1%)
	Male	1472 (42.4%)
	Unknown	399 (11.5%)
Weight, kg
	< 50	131 (3.8%)
	50-100	710 (20.5%)
	> 100	333 (9.6%)
	Unknown	2297 (66.2%)
	Median [Q1, Q3)]	71 [57, 164]
Indication (Top Five)
	Non-small cell lung cancer	184 (5.3%)
	Breast cancer	145 (4.2%)
	Metastatic malignant melanoma	93 (2.7%)
	Malignant melanoma	79 (2.3%)
	Renal cell carcinoma	75 (2.2%)
Reporter
	Health-care professional	2944 (84.8%)
	Non-health-care professional	411 (11.8%)
Outcome
	Death	1111 (32.0%)
	Disability	18 (0.5%)
	Life-threatening	447 (12.9%)
	Hospitalization	1072 (30.9%)
	Required intervention to prevent permanent impairment	4 (0.1%)
	Other Serious	802 (23.1%)

SJS/TEN, Stevens-Johnson syndrome and toxic epidermal necrolysis; Unknown, Missing data.